RGX-314 - REGENXBIO, AbbVie
Vabysmo (faricimab-svoa) - Roche
sozinibercept (OPT-302) - Opthea
Syfovre (pegcetacoplan intravitreal) - Apellis
Lucentis (ranibizumab) - Roche, Novartis
http://www.ncbi.nlm.nih.gov/pubmed/38330506
 
Christos Papaioannou
 
Feb 9, 2024
 
Prev Next